{"filing":{"accession_number":"0001171843-26-005078","cik":"0001832466","ticker":"ALHC","company_name":"Alignment Healthcare, Inc.","form":"8-K","filing_date":"2026-07-30","report_date":"2026-07-30","primary_document":"f8k_073026.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1832466/000117184326005078/f8k_073026.htm"},"events":[{"id":22575,"run_id":20424,"accession_number":"0001171843-26-005078","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release discloses comprehensive financial results including total revenue of $1.3 billion (31.6% YoY growth), membership growth of 31.5% YoY to 294,100 members, adjusted gross profit of $182.9 million (35.3% YoY growth), and adjusted EBITDA of $68.1 million (48.4% YoY growth), along with forward guidance for Q3 and full-year 2026. The filing includes condensed consolidated financial statements and is furnished as Exhibit 99.1 per Item 2.02.","company_name":"Alignment Healthcare, Inc.","ticker":"ALHC","filing_date":"2026-07-30","form":"8-K","submitted_at":null,"items":[{"id":22554,"accession_number":"0001171843-26-005078","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release discloses comprehensive financial results including total revenue of $1.3 billion (31.6% YoY growth), membership growth of 31.5% YoY to 294,100 members, adjusted gross profit of $182.9 million (35.3% YoY growth), and adjusted EBITDA of $68.1 million (48.4% YoY growth), along with forward guidance for Q3 and full-year 2026. The filing includes condensed consolidated financial statements and is furnished as Exhibit 99.1 per Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:20:28.472148+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22554,"accession_number":"0001171843-26-005078","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release discloses comprehensive financial results including total revenue of $1.3 billion (31.6% YoY growth), membership growth of 31.5% YoY to 294,100 members, adjusted gross profit of $182.9 million (35.3% YoY growth), and adjusted EBITDA of $68.1 million (48.4% YoY growth), along with forward guidance for Q3 and full-year 2026. The filing includes condensed consolidated financial statements and is furnished as Exhibit 99.1 per Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T02:20:28.472148+00:00","company_name":"Alignment Healthcare, Inc.","ticker":"ALHC","filing_date":"2026-07-30"}]}